Drawing for PHARMAC3

USPTO serial 75547320

PHARMAC3

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
RICHARDS, LESLIE
Law office
FILE REPOSITORY (FRANCONIA)

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with PHARMAC3?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

ERNEST B LIPSCOMB III

ERNEST B LIPSCOMB III P O DRAWER 34009ALSTON & BIRD LLPCHARLOTTE, NC 28234UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
016Pharmaceutical publications and direct mail printed promotional materials for others, namely, pamphlets, brochures, printed package inserts, journals, magazines, printed packaging constructed of paper products, booklets, cards, catalogs, and printed point-of-sale displays constructed of paper products in the field of medicine and pharmacologyACTIVE—
035Distributorship services featuring pharmaceutical publications and direct mail printed promotional materials for others, namely, pamphlets, brochures, printed package inserts, journals, magazines, printed packaging composed of paper products, booklets, cards, catalogs, and printed point-of-sale displays composed of paper products in the field of medicine and pharmacologyACTIVE—
042Design and printing for others of pharmaceutical publications and direct mail printed promotional materials, namely, pamphlets, brochures, printed package inserts, journals, magazines, printed packaging composed of paper products, booklets, cards, catalogs, and printed point-of-sale displays composed of paper products in the field of medicine and pharmacologyACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (ABN6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Mar 31, 2001ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
May 30, 2000NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 7, 2000PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 4, 2000NPUBNOTICE OF PUBLICATION—
Dec 22, 1999CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 15, 1999CNEAEXAMINER'S AMENDMENT MAILED—
Dec 9, 1999CNEAEXAMINER'S AMENDMENT MAILED—
Oct 4, 1999CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 1, 1999CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 2, 1999DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance